Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2025-12-25 @ 12:18 AM
NCT ID:
NCT05694858
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 years old and above
* Patients requiring venepuncture for blood investigations before ophthalmological procedures
Exclusion Criteria:
* Patient with a previous history of sensitization or allergy to lignocaine.
* Patient with a previous history of allergy to materials used in the study i.e., plaster, electrodes, maltose, Polyvinyl Alcohol (PVA), and Polyethylene Terephthalate (PET)
* Patient exposed to analgesic usage within 24 hours prior to the procedure
* Generalized skin disorder/ rash
* Agitated/ fretful / uncooperative patient
* Uncommunicative/deaf/mute patients
* Patients on hypnotics, or chronic pain relief medications
* Patients with psychiatric conditions
* Patients with hepatic impairment
* Patients who are on CYP450 3A4, 3A5 or 1A2-inducing or inhibiting drugs (erythromycin, ciprofloxacin, amiodarone etc.) or pharmacotherapeutic agents that affect hepatic blood flow (metoprolol) since both may affect the metabolism of lignocaine
* Failed first/single attempt at venepuncture after the application of the LEMAP or PET patch for control arm.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05694858
Study Brief:
Protocol Section:
NCT05694858